Gender-specific hypertension and responsiveness to nitric oxide in sGCα1 knockout mice

Cardiovascular Research

Volumn 79, Issue 1, 2008, Pages 179-186

  Buys, Emmanuel S ^a,b,c   Sips, Patrick ^a,b   Vermeersch, Pieter ^d   Raher, Michael J ^c   Rogge, Elke ^a,b   Ichinose, Fumito ^c   Dewerchin, Mieke ^d   Bloch, Kenneth D ^c   Janssens, Stefan ^d   Brouckaert, Peter ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Blood pressure; Gender; Hypertension; Nitric oxide; Ventricular function

Indexed keywords

CYCLIC GMP; GUANYLATE CYCLASE; NITRIC OXIDE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY COMPLIANCE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; ENZYME SYNTHESIS; FEMALE; GENDER; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE RELAXATION; HEART VENTRICLE FUNCTION; HEMODYNAMICS; HORMONAL THERAPY; HYPERTENSION; MALE; MOUSE; NONHUMAN; ORCHIECTOMY; OVARIECTOMY; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; BLOOD PRESSURE; CYCLIC GMP; FEMALE; GUANYLATE CYCLASE; HYPERTENSION; ISOENZYMES; MALE; MICE; MYOCARDIAL CONTRACTION; NITRIC OXIDE; ORCHIECTOMY; OVARIECTOMY; PYRAZOLES; PYRIDINES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION; TESTOSTERONE; VASCULAR RESISTANCE;

EID: 45849123153     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn068     Document Type: Article

References (32)

1. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995;377:239-242.
2. Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE et al. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1996;93:13176-13181.
3. Feil R, Lohmann SM, de Jonge H, Walter U, Hofmann F. Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice. Circ Res 2003;93:907-916.
4. Hofmann F, Biel M, Feil R, Kleppisch T. Mouse models of NO/natriuretic peptide/cGMP kinase signaling. In: Offermanns S, Hein L, ed. Handbook of Experimental Pharmacology, Vol. 159. Heidelberg, Germany: Springer-Verlag; 2004. p95-130.
5. Lincoln TM, Dey N, Sellak H. Invited review: cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression. J Appl Physiol 2001;91:1421-1430.
6. Koesling D, Russwurm M, Mergia E, Mullershausen F, Friebe A. Nitric oxide-sensitive guanylyl cyclase: structure and regulation. Neurochem Int 2004;45:813-819.
7. Russwurm M, Koesling D. Guanylyl cyclase: NO hits its target. Biochem Soc Symp 2004;51-63.
8. Vermeersch P, Buys E, Pokreisz P, Marsboom G, Ichinose F, Sips P et al. Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia. Circulation 2007;116:936-943.
9. Friebe A, Mergia E, Dangel O, Lange A, Koesling D. Fatal gastrointestinal obstruction and hypertension in mice lacking nitric oxide-sensitive guanylyl cyclase. Proc Natl Acad Sci USA 2007;104:7699-7704.
10. Mergia E, Friebe A, Dangel O, Russwurm M, Koesling D. Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system. J Clin Invest 2006;116:1731-1737.
11. Nimmegeers S, Sips P, Buys E, Brouckaert P, Van de Voorde J. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation. Cardiovasc Res 2007;76:149-159.
12. Evgenov OV, Pacher P, Schmidt PM, Hasko G, Schmidt HH, Stasch JP. NO-independent stimulators andactivators of soluble guanylate cyclase: discovery and therapeutic potential. Nat Rev Drug Discov 2006;5:755-768.
13. Muller B, Kleschyov AL, Malblanc S, Stoclet JC. Nitric oxide-related cyclic GMP-independent relaxing effect of N-acetylcysteine in lipopolysaccharide-treated rat aorta. Br J Pharmacol 1998;123: 1221-1229.
14. Nakagawa M, Takeuchi T, Niioka S, Yamaji M, Okishio Y, Nishio H et al. 1H-[1,2,4] oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) inhibits cyclic GMP-PKG pathway-independent nonadrenergic, noncholinergic relaxation in longitudinal muscle of the rectum of Wistar-ST rats. Jpn J Pharmacol 2000;82:164-167.
15. Wegener JW, Closs EI, Forstermann U, Nawrath H. Failure of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) to inhibit soluble guanylyl cyclase in rat ventricular cardiomyocytes. Br J Pharmacol 1999;127:693-700.
16. Zhao Y, Brandish PE, DiValentin M, Schelvis JP, Babcock GT, Marletta MA. Inhibition of soluble guanylate cyclase by ODQ. Biochemistry 2000;39:10848-10854.
17. Krege JH, Hodgin JB, Hagaman JR, Smithies O. A noninvasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension 1995;25:1111-1115.
18. Ichinose F, Bloch KD, Wu JC, Hataishi R, Aretz HT, Picard MH et al. Pressure overload-induced LV hypertrophy and dysfunction in mice are exacerbated by congenital NOS3 deficiency. Am J Physiol Heart Circ Physiol 2004;286:H1070-H1075.
19. Scherrer-Crosbie M, Ullrich R, Bloch KD, Nakajima H, Nasseri B, Aretz HT et al. Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice. Circulation 2001;104:1286-1291.
20. Denninger JW, Marletta MA. Guanylate cyclase and the.NO/cGMP signaling pathway. Biochim Biophys Acta 1999;1411:334-350.
21. Wedel B, Harteneck C, Foerster J, Friebe A, Schultz G, Koesling D. Functional domains of soluble guanylyl cyclase. J Biol Chem 1995;270:24871-24875.
22. Koglin M, Stasch JP, Behrends S. BAY 41-2272 activates two isoforms of nitric oxide-sensitive guanylyl cyclase. Biochem Biophys Res Commun 2002;292:1057-1062.
23. Wegener JW, Nawrath H, Wolfsgruber W, Kuhbandner S, Werner C, Hofmann F et al. cGMP-dependent protein kinase I mediates the negative inotropic effect of cGMP in the murine myocardium. Circ Res 2002;90:18-20.
24. Scotland RS, Madhani M, Chauhan S, Moncada S, Andresen J, Nilsson H et al. Investigation of vascular responses in endothelial nitric oxide synthase/cyclooxygenase-1 double-knockout mice: key role for endothelium-derived hyperpolarizing factor in the regulation of blood pressure in vivo. Circulation 2005;111:796-803.
25. Regitz-Zagrosek V. Therapeutic implications of the gender-specific aspects of cardiovascular disease. Nat Rev Drug Discov 2006;5:425-438.
26. Chambliss KL, Shaul PW. Estrogen modulation of endothelial nitric oxide synthase. Endocr Rev 2002;23:665-686.
27. Dubey RK, Oparil S, Imthurn B, Jackson EK. Sex hormones and hypertension. Cardiovasc Res 2002;53:688-708.
28. Guo X, Lu X, Ren H, Levin ER, Kassab GS. Estrogen modulates the mechanical homeostasis of mouse arterial vessels through nitric oxide. Am J Physiol Heart Circ Physiol 2006;290:H1788-H1797.
29. Li Y, Kishimoto I, Saito Y, Harada M, Kuwahara K, Izumi T et al. Androgen contributes to gender-related cardiac hypertrophy and fibrosis in mice lacking the gene encoding guanylyl cyclase-A. Endocrinology 2004;145:951-958.
30. Reckelhoff JF, Zhang H, Srivastava K, Granger JP. Gender differences in hypertension in spontaneously hypertensive rats: role of androgens and androgen receptor. Hypertension 1999;34:920-923.
31. Koeppen M, Feil R, Siegl D, Feil S, Hofmann F, Pohl U et al. cGMP-dependent protein kinase mediates NO- but not acetylcholine-induced dilations in resistance vessels in vivo. Hypertension 2004;44:952-955.
32. Pfeifer A, Klatt P, Massberg S, Ny L, Sausbier M, Hirneiss C et al. Defective smooth muscle regulation in cGMP kinase I-deficient mice. Embo J 1998;17:3045-3051.